Cerebral venous thrombosis.
Neuroimagining facilities allow early recognition of cerebral venous thrombosis (CVT), which now appears far more common than previously assumed. The diagnosis remains difficult because of a wide spectrum of clinical presentation and a highly variable mode of onset. Numerous conditions (presently mostly noninfectious) can cause or predispose to CVT, which therefore requires an extensive etiologic work-up. The functional and vital prognosis is much better than classically thought with, in noninfectious CVT, a fatality rate of less than 10% and a complete recovery in over 70%. Although spontaneous recovery is possible, the efficacy of heparin is now well established.
Ameri
A
A
Service de Neurologie, Hôpital Saint-Antoine, Paris, France.
Bousser
M G
MG
D000925:Anticoagulants / Q000627:therapeutic use; D002533:Cerebral Angiography; D002550:Cerebral Veins / Q000000981:diagnostic imaging / Q000187:drug effects; D003131:Combined Modality Therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000175:diagnosis* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D011379:Prognosis; D012851:Sinus Thrombosis, Intracranial / Q000175:diagnosis* / Q000188:drug therapy; D014057:Tomography, X-Ray Computed
D000925:Anticoagulants; D005343:Fibrinolytic Agents